1084 — Green Fresh Biotechnology Co Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesAdventurousSmall CapNeutral

Annual income statement for Green Fresh Biotechnology Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	fx Final	Final	Final	Final	Final
Revenue
Total Revenue	965	1,411	1,174	989	905
Cost of Revenue
Gross Profit	224	384	37.6	222	167
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	832	1,122	1,246	879	870
Operating Profit	133	289	-72.4	110	34.6
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	114	262	-113	80.9	7.12
Provision for Income Taxes
Net Income After Taxes	86.3	200	-85.4	60.9	5.37
Minority Interest
Net Income Before Extraordinary Items
Net Income	86	199	-85.3	62.2	6.59
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	86	199	-85.3	62.2	6.59
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.108	0.24	-0.103	0.074	0.008
Dividends per Share